Sheridan Larsenovna Shailieva
Research Subjects
Research Interests
Sheridan Larsenovna Shailieva has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- A. A. Kutseva
Pirogov Russian National Research Medical University, Health Ministry of Russian Federation
1 shared publication - A. P. Vishnevskaya
Dagestan State Medical University, Health Ministry of Russian Federation
1 shared publication - A. S. Vinogradova
Stavropol State Medical University, Health Ministry of Russian Federation
1 shared publication - A. V. Sineva
Bashkir State Medical University, Health Ministry of Russian Federation
1 shared publication - Alina Rashidovna Kasimova
Vreden National Medical Research Center of Traumatology and Orthopedics; Pavlov First Saint Petersburg State Medical University
1 shared publication - D. Kh. Mamchueva
North Caucasian State Academy
1 shared publication
Latest Publications
- 25 June 2026
- Published by Russian Ilizarov Scientific Centre Restorative Traumatology and Orthopaedics in Genij Ortopedii
- Vol. 32 (3)
Anti-edematous effect of escin lysinate in patients treated with corrective foot osteotomy
Introduction Surgical treatment of the forefoot deformities using corrective osteotomies can be associated with local reactions, manifested by postoperative swelling and pain. The factors can impact the timing and quality of early patient rehabilitation. The search for safe and effective means to relieve postoperative swelling and pain is essential in modern traumatology and orthopedics. The escin lysinate solution with angioprotective, anti-edematous, and analgesic effects, is considered as a pathogenetically substantiated approach. The objective was to compare the efficacy and safety of escin lysinate used to reduce postoperative swelling and pain in patients after corrective osteotomies of the foot and the standard therapy and therapy supplemented with a short course of systemic glucocorticosteroids. Material and methods A prospective randomized study included 30 patients (18–70 years) who underwent SCARF osteotomy of the first metatarsal bone, AKIN osteotomy, and/or Weil osteotomy. Patients were divided into three groups (10 individuals each) who underwent standard therapy (control); standard therapy + escin lysinate; standard therapy + dexamethasone. The severity of swelling of the limb, pain assessed with the visual analog scale (VAS), the need for nonsteroidal anti-inflammatory drugs (NSAIDs), the level of C-reactive protein, and the safety of therapy were dynamically evaluated. Results The pain significantly reduced in the first three postoperative days in the escin lysinate group as compared to the control group with a reduced need for NSAIDs. A greater edema regression was observed at the metatarsal level at six weeks. Dynamics in pain was noted in the dexamethasone group at a short term with a less need for NSAIDs. No adverse reactions or clinically significant changes in laboratory parameters were recorded. Discussion Postoperative edema was more evident in the foot as compared to other anatomical sites due to limited soft tissue volume and slow venous and lymphatic outflow from the distal extremities. In this context, medications that reduce vascular and tissue permeability play a role. Aescin lysinate was shown to demonstrate efficacy in neurosurgery and otolaryngology with the use being associated with reduceed edema and inflammation. In orthopedics and traumatology, the drug demonstrated angioprotective and analgesic potential in lower extremity injuries. Unlike systemic glucocorticosteroids such as dexamethasone having a pronounced but short-term anti-inflammatory effect and being associated with the risk of hyperglycemia, infections and bone loss, escin lysinate has a safety profile and can be considered as a pathogenetically justified agent for the control of postoperative inflammation and edema. Conclusion A comparative evaluation of the adjuvant use of escin lysinate, standard therapy, and therapy supplemented with a short course of systemic glucocorticosteroids after corrective foot osteotomies demonstrated earlier pain relief and accelerated edema resolution with no risk of adverse reactions with escin lysinate. The drug can be considered an effective and safe addition to standard therapy, providing a more favorable early postoperative effect.
- 25 June 2026
- Published by Russian Ilizarov Scientific Centre Restorative Traumatology and Orthopaedics in Genij Ortopedii
- Vol. 32 (3)
Anti-edematous effect of escin lysinate in patients treated with corrective foot osteotomy
Introduction Surgical treatment of the forefoot deformities using corrective osteotomies can be associated with local reactions, manifested by postoperative swelling and pain. The factors can impact the timing and quality of early patient rehabilitation. The search for safe and effective means to relieve postoperative swelling and pain is essential in modern traumatology and orthopedics. The escin lysinate solution with angioprotective, anti-edematous, and analgesic effects, is considered as a pathogenetically substantiated approach. The objective was to compare the efficacy and safety of escin lysinate used to reduce postoperative swelling and pain in patients after corrective osteotomies of the foot and the standard therapy and therapy supplemented with a short course of systemic glucocorticosteroids. Material and methods A prospective randomized study included 30 patients (18–70 years) who underwent SCARF osteotomy of the first metatarsal bone, AKIN osteotomy, and/or Weil osteotomy. Patients were divided into three groups (10 individuals each) who underwent standard therapy (control); standard therapy + escin lysinate; standard therapy + dexamethasone. The severity of swelling of the limb, pain assessed with the visual analog scale (VAS), the need for nonsteroidal anti-inflammatory drugs (NSAIDs), the level of C-reactive protein, and the safety of therapy were dynamically evaluated. Results The pain significantly reduced in the first three postoperative days in the escin lysinate group as compared to the control group with a reduced need for NSAIDs. A greater edema regression was observed at the metatarsal level at six weeks. Dynamics in pain was noted in the dexamethasone group at a short term with a less need for NSAIDs. No adverse reactions or clinically significant changes in laboratory parameters were recorded. Discussion Postoperative edema was more evident in the foot as compared to other anatomical sites due to limited soft tissue volume and slow venous and lymphatic outflow from the distal extremities. In this context, medications that reduce vascular and tissue permeability play a role. Aescin lysinate was shown to demonstrate efficacy in neurosurgery and otolaryngology with the use being associated with reduceed edema and inflammation. In orthopedics and traumatology, the drug demonstrated angioprotective and analgesic potential in lower extremity injuries. Unlike systemic glucocorticosteroids such as dexamethasone having a pronounced but short-term anti-inflammatory effect and being associated with the risk of hyperglycemia, infections and bone loss, escin lysinate has a safety profile and can be considered as a pathogenetically justified agent for the control of postoperative inflammation and edema. Conclusion A comparative evaluation of the adjuvant use of escin lysinate, standard therapy, and therapy supplemented with a short course of systemic glucocorticosteroids after corrective foot osteotomies demonstrated earlier pain relief and accelerated edema resolution with no risk of adverse reactions with escin lysinate. The drug can be considered an effective and safe addition to standard therapy, providing a more favorable early postoperative effect.
- Open Access
- 24 October 2025
- Published by ECO-Vector LLC in Traumatology and Orthopedics of Russia
- Vol. 31 (4) , 179-188
Subsidence of vertebral body replacement prostheses in spinal tumors: a systematic review
Background. Vertebral body replacement is one of the key surgical methods for the treatment of spinal tumors. One of its most common complications is vertebral body implant subsidence. The aim of the review — to compare the subsidence rates of various types of vertebral body implants used in the surgical treatment of thoracic and lumbar spinal tumors in order to determine the optimal reconstruction methods for patients with spinal tumors. Methods. A systematic literature review was conducted in accordance with the PRISMA guidelines. The search was performed in the PubMed, Google Scholar, and eLIBRARY databases. Studies were included if they involved vertebral body replacement in patients aged 18 years and older with oncologic lesions, provided a clear definition of subsidence, and analyzed risk factors. Various implant types were evaluated, including expandable, mesh, 3D-printed commercial, and patient-specific prostheses. Results. Thirteen studies were included in the analysis (12 retrospective and 1 prospective) comprising a total of 661 patients. The highest subsidence rates were observed with titanium mesh cages, ranging from 63.8 to 71.4%. Expandable implants demonstrated more favorable outcomes, with subsidence rates from 5.3 to 35.3%. The results for 3D-printed implants were the most inconsistent, ranging from 0 to 100% across studies. The follow-up period varied from 7.4 to 101 months. Conclusions. Expandable implants demonstrate the most favorable subsidence rates in vertebral body replacement for patients with spinal tumors. The high subsidence rates of titanium mesh cages may be attributed to a mismatch between the elastic modulus of the implant and bone tissue. 3D-printed implants require further investigation to optimize their design and clinical use. An individualized approach to prosthesis selection considering risk factors is essential.
- 24 October 2025
- Published by ECO-Vector LLC in Traumatology and Orthopedics of Russia
- Vol. 31 (4) , 179-188
Open AccessSubsidence of vertebral body replacement prostheses in spinal tumors: a systematic review
Background. Vertebral body replacement is one of the key surgical methods for the treatment of spinal tumors. One of its most common complications is vertebral body implant subsidence. The aim of the review — to compare the subsidence rates of various types of vertebral body implants used in the surgical treatment of thoracic and lumbar spinal tumors in order to determine the optimal reconstruction methods for patients with spinal tumors. Methods. A systematic literature review was conducted in accordance with the PRISMA guidelines. The search was performed in the PubMed, Google Scholar, and eLIBRARY databases. Studies were included if they involved vertebral body replacement in patients aged 18 years and older with oncologic lesions, provided a clear definition of subsidence, and analyzed risk factors. Various implant types were evaluated, including expandable, mesh, 3D-printed commercial, and patient-specific prostheses. Results. Thirteen studies were included in the analysis (12 retrospective and 1 prospective) comprising a total of 661 patients. The highest subsidence rates were observed with titanium mesh cages, ranging from 63.8 to 71.4%. Expandable implants demonstrated more favorable outcomes, with subsidence rates from 5.3 to 35.3%. The results for 3D-printed implants were the most inconsistent, ranging from 0 to 100% across studies. The follow-up period varied from 7.4 to 101 months. Conclusions. Expandable implants demonstrate the most favorable subsidence rates in vertebral body replacement for patients with spinal tumors. The high subsidence rates of titanium mesh cages may be attributed to a mismatch between the elastic modulus of the implant and bone tissue. 3D-printed implants require further investigation to optimize their design and clinical use. An individualized approach to prosthesis selection considering risk factors is essential.
- Open Access
- 6 May 2024
- Published by IRBIS in Obstetrics, Gynecology and Reproduction
- Vol. 18 (4) , 563-580
An opportunity for using artificial intelligence in modern gynecology
Introduction. Artificial intelligence (AI) is a technology that simulates human brain data processing, its intellectual behavior and critical thinking. Sophisticated AI models can potentially improve patient management by speeding up processes and increasing their accuracy and efficiency at a lower cost of human resources. Compared to other specialties, use of AI in gynecology remains in its infancy. It is important to understand that the available methods for clinical imaging have certain limitations, namely clinician's workload and data variably interpreted by different doctors. AI, in turn, has the potential to overcome these limitations while increasing diagnostic accuracy.Aim: to structure and analyze current published data on AI use in gynecology.Materials and Methods. A search for primary sources was carried out in the electronic databases PubMed, eLibrary and Google Scholar. The search queries included the following keywords "artificial intelligence", "gynecology", "endometrial cancer", "endometriosis", "ovarian cancer", "diagnostics", "oncogynecology" retrieved from February 2014 to February 2024. Articles were assessed according to PRISMA guidelines. After identification, before the screening stage, duplicates were excluded. At the screening stage, the titles and annotations of the identified articles were analyzed for eligibility to the review topic as well as for available full-text versions; abstracts and letters to the editorial board in scientific journals were excluded at this stage. 685 full-text articles were evaluated for eligibility, the inclusion criteria were as follows: publication in Russian or English; the study describes use of AI technologies in diagnostics or treatment of gynecological diseases. All disagreements between authors were resolved by consensus. Ultimately, 80 primary sources were included in this review.Results. AI-based systems have succeeded in image analyzing and interpreting and over the past decade have become powerful tools that have revolutionized the field of gynecological imaging. In the studies analyzed, AI was able to provide faster and more accurate forecasts and diagnostics, increasing the overall effectiveness of gynecological care. It is important to note that AI cannot fully replace doctors, but it can perfectly integrate into clinical practice, helping in the decision-making process and reducing errors in differential diagnosis and variability of interaction between different specialists. In the field of oncogynecology, undoubtedly one of the most promising aspects is the possibility of better and especially early diagnostics and, ultimately, improved patient survival.Conclusion. A great success has been achieved so far, and AI use is expected to extend in the next few years. In fact, it will take a very long way to go before AI-based technologies are fully integrated into clinical practice.
- 6 May 2024
- Published by IRBIS in Obstetrics, Gynecology and Reproduction
- Vol. 18 (4) , 563-580
Open AccessAn opportunity for using artificial intelligence in modern gynecology
Introduction. Artificial intelligence (AI) is a technology that simulates human brain data processing, its intellectual behavior and critical thinking. Sophisticated AI models can potentially improve patient management by speeding up processes and increasing their accuracy and efficiency at a lower cost of human resources. Compared to other specialties, use of AI in gynecology remains in its infancy. It is important to understand that the available methods for clinical imaging have certain limitations, namely clinician's workload and data variably interpreted by different doctors. AI, in turn, has the potential to overcome these limitations while increasing diagnostic accuracy.Aim: to structure and analyze current published data on AI use in gynecology.Materials and Methods. A search for primary sources was carried out in the electronic databases PubMed, eLibrary and Google Scholar. The search queries included the following keywords "artificial intelligence", "gynecology", "endometrial cancer", "endometriosis", "ovarian cancer", "diagnostics", "oncogynecology" retrieved from February 2014 to February 2024. Articles were assessed according to PRISMA guidelines. After identification, before the screening stage, duplicates were excluded. At the screening stage, the titles and annotations of the identified articles were analyzed for eligibility to the review topic as well as for available full-text versions; abstracts and letters to the editorial board in scientific journals were excluded at this stage. 685 full-text articles were evaluated for eligibility, the inclusion criteria were as follows: publication in Russian or English; the study describes use of AI technologies in diagnostics or treatment of gynecological diseases. All disagreements between authors were resolved by consensus. Ultimately, 80 primary sources were included in this review.Results. AI-based systems have succeeded in image analyzing and interpreting and over the past decade have become powerful tools that have revolutionized the field of gynecological imaging. In the studies analyzed, AI was able to provide faster and more accurate forecasts and diagnostics, increasing the overall effectiveness of gynecological care. It is important to note that AI cannot fully replace doctors, but it can perfectly integrate into clinical practice, helping in the decision-making process and reducing errors in differential diagnosis and variability of interaction between different specialists. In the field of oncogynecology, undoubtedly one of the most promising aspects is the possibility of better and especially early diagnostics and, ultimately, improved patient survival.Conclusion. A great success has been achieved so far, and AI use is expected to extend in the next few years. In fact, it will take a very long way to go before AI-based technologies are fully integrated into clinical practice.